BRISTOL-MYERS SQUIBB COMPANY Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax of -$2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2026-06-30 was -$2.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2026-03-31 was -$9.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2025-03-31 was -$2.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2024-12-31 was -$46.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2025 was -$99.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2024 was -$83.00M, a 159.29% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2023 was $140.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2022 was -$178.00M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.00M 10-Q · filed 2026-07-30 | -$10.00M 10-Q · filed 2026-07-30 | ||
| 2026-03-31 | -$9.00M 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | -$99.00M 10-K · filed 2026-02-11 | |||
| 2025-03-31 | -$2.00M 10-Q · filed 2026-04-30 | -$48.00M derived: sum of 2 quarters · filed 2026-04-30 | -$156.00M derived: sum of 3 quarters · filed 2026-04-30 | -$70.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$154.00M derived: sum of 2 quarters · filed 2026-02-11 | -$68.00M derived: sum of 3 quarters · filed 2026-02-11 | -$83.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$108.00M 10-Q · filed 2024-10-31 | -$22.00M derived: sum of 2 quarters · filed 2024-10-31 | -$37.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $86.00M 10-Q · filed 2024-07-26 | $71.00M 10-Q · filed 2024-07-26 | ||
| 2024-03-31 | -$15.00M 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | $140.00M 10-K · filed 2026-02-11 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-25 | -$98.00M derived: sum of 2 quarters · filed 2025-02-12 | -$121.00M derived: sum of 3 quarters · filed 2025-02-12 | -$151.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$121.00M derived: sum of 2 quarters · filed 2025-02-12 | -$151.00M derived: sum of 3 quarters · filed 2025-02-12 | -$178.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$23.00M 10-Q · filed 2023-10-26 | -$53.00M derived: sum of 2 quarters · filed 2023-10-26 | -$80.00M 10-Q · filed 2023-10-26 | -$280.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | -$30.00M 10-Q · filed 2023-07-27 | -$57.00M 10-Q · filed 2023-07-27 | -$257.00M derived: sum of 3 quarters · filed 2024-02-13 | -$265.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | -$27.00M 10-Q · filed 2023-04-27 | -$227.00M derived: sum of 2 quarters · filed 2024-02-13 | -$235.00M derived: sum of 3 quarters · filed 2024-02-13 | -$251.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$208.00M derived: sum of 2 quarters · filed 2024-02-13 | -$224.00M derived: sum of 3 quarters · filed 2024-02-13 | -$255.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$8.00M 10-Q · filed 2022-10-26 | -$24.00M derived: sum of 2 quarters · filed 2022-10-26 | -$55.00M 10-Q · filed 2022-10-26 | $42.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$16.00M 10-Q · filed 2022-07-27 | -$47.00M 10-Q · filed 2022-07-27 | $50.00M derived: sum of 3 quarters · filed 2023-02-14 | $54.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$31.00M 10-Q · filed 2022-04-29 | $66.00M derived: sum of 2 quarters · filed 2023-02-14 | $70.00M derived: sum of 3 quarters · filed 2023-02-14 | $79.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $97.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $101.00M derived: sum of 2 quarters · filed 2023-02-14 | $110.00M derived: sum of 3 quarters · filed 2023-02-14 | $91.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $4.00M 10-Q · filed 2021-10-27 | $13.00M derived: sum of 2 quarters · filed 2021-10-27 | -$6.00M 10-Q · filed 2021-10-27 | -$10.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $9.00M 10-Q · filed 2021-07-28 | -$10.00M 10-Q · filed 2021-07-28 | -$14.00M derived: sum of 3 quarters · filed 2022-02-09 | -$1.45B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | -$19.00M 10-Q · filed 2021-04-29 | -$23.00M derived: sum of 2 quarters · filed 2022-02-09 | -$1.46B derived: sum of 3 quarters · filed 2022-02-09 | -$1.51B derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$1.44B derived: sum of 2 quarters · filed 2022-02-09 | -$1.49B derived: sum of 3 quarters · filed 2022-02-09 | -$1.55B 10-K · filed 2022-02-09 |
| 2019-09-30 | -$1.44B 10-Q · filed 2020-11-05 | -$1.48B derived: sum of 2 quarters · filed 2020-11-05 | -$1.55B 10-Q · filed 2020-11-05 | -$1.40B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | -$48.00M 10-Q · filed 2020-08-06 | -$112.00M 10-Q · filed 2020-08-06 | $36.00M derived: sum of 3 quarters · filed 2021-02-10 | $8.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | -$64.00M 10-Q · filed 2020-05-07 | $84.00M derived: sum of 2 quarters · filed 2021-02-10 | $56.00M derived: sum of 3 quarters · filed 2021-02-10 | $2.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $148.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $120.00M derived: sum of 2 quarters · filed 2021-02-10 | $66.00M derived: sum of 3 quarters · filed 2021-02-10 | -$97.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | -$28.00M 10-Q · filed 2019-10-31 | -$82.00M derived: sum of 2 quarters · filed 2019-10-31 | -$245.00M 10-Q · filed 2019-10-31 | -$423.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | -$54.00M 10-Q · filed 2019-07-25 | -$217.00M 10-Q · filed 2019-07-25 | -$395.00M derived: sum of 3 quarters · filed 2020-02-24 | -$430.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | -$163.00M 10-Q · filed 2019-04-25 | -$341.00M derived: sum of 2 quarters · filed 2020-02-24 | -$376.00M derived: sum of 3 quarters · filed 2020-02-24 | -$344.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | -$178.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$213.00M derived: sum of 2 quarters · filed 2020-02-24 | -$181.00M derived: sum of 3 quarters · filed 2020-02-24 | -$291.00M 10-K · filed 2020-02-24 |
| 2017-09-30 | -$35.00M 10-Q · filed 2018-10-25 | -$3.00M derived: sum of 2 quarters · filed 2018-10-25 | -$113.00M 10-Q · filed 2018-10-25 | -$487.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $32.00M 10-Q · filed 2018-07-26 | -$78.00M 10-Q · filed 2018-07-26 | -$452.00M derived: sum of 3 quarters · filed 2019-02-25 | -$563.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$110.00M 10-Q · filed 2018-04-26 | -$484.00M derived: sum of 2 quarters · filed 2019-02-25 | -$595.00M derived: sum of 3 quarters · filed 2019-02-25 | -$406.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | -$374.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$485.00M derived: sum of 2 quarters · filed 2019-02-25 | -$296.00M derived: sum of 3 quarters · filed 2019-02-25 | -$43.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | -$111.00M 10-Q · filed 2017-10-26 | $78.00M derived: sum of 2 quarters · filed 2017-10-26 | $331.00M 10-Q · filed 2017-10-26 | $372.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $189.00M 10-Q · filed 2017-07-27 | $442.00M 10-Q · filed 2017-07-27 | $483.00M derived: sum of 3 quarters · filed 2018-02-13 | $687.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $253.00M 10-Q · filed 2017-04-27 | $294.00M derived: sum of 2 quarters · filed 2018-02-13 | $498.00M derived: sum of 3 quarters · filed 2018-02-13 | $26.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $245.00M derived: sum of 2 quarters · filed 2018-02-13 | -$227.00M derived: sum of 3 quarters · filed 2018-02-13 | -$157.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $204.00M 10-Q · filed 2016-10-27 | -$268.00M derived: sum of 2 quarters · filed 2016-10-27 | -$198.00M 10-Q · filed 2016-10-27 | -$527.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | -$472.00M 10-Q · filed 2016-07-28 | -$402.00M 10-Q · filed 2016-07-28 | -$731.00M derived: sum of 3 quarters · filed 2017-02-21 | -$106.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $70.00M 10-Q · filed 2016-04-28 | -$259.00M derived: sum of 2 quarters · filed 2017-02-21 | $366.00M derived: sum of 3 quarters · filed 2017-02-21 | $343.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | -$329.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $296.00M derived: sum of 2 quarters · filed 2017-02-21 | $273.00M derived: sum of 3 quarters · filed 2017-02-21 | $443.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $625.00M 10-Q · filed 2015-10-27 | $602.00M derived: sum of 2 quarters · filed 2015-10-27 | $772.00M 10-Q · filed 2015-10-27 | $450.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | -$23.00M 10-Q · filed 2015-07-23 | $147.00M 10-Q · filed 2015-07-23 | -$175.00M derived: sum of 3 quarters · filed 2016-02-12 | -$510.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $170.00M 10-Q · filed 2015-04-28 | -$152.00M derived: sum of 2 quarters · filed 2016-02-12 | -$487.00M derived: sum of 3 quarters · filed 2016-02-12 | -$1.56B derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | -$322.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$657.00M derived: sum of 2 quarters · filed 2016-02-12 | -$1.73B derived: sum of 3 quarters · filed 2016-02-12 | -$1.77B 10-K · filed 2016-02-12 |
| 2013-09-30 | -$335.00M 10-Q · filed 2014-10-24 | -$1.41B derived: sum of 2 quarters · filed 2014-10-24 | -$1.45B 10-Q · filed 2014-10-24 | -$1.18B derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | -$1.07B 10-Q · filed 2014-07-24 | -$1.11B 10-Q · filed 2014-07-24 | -$848.00M derived: sum of 3 quarters · filed 2015-02-13 | -$884.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | -$38.00M 10-Q · filed 2014-04-29 | $226.00M derived: sum of 2 quarters · filed 2015-02-13 | $190.00M derived: sum of 3 quarters · filed 2015-02-13 | $157.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $264.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $228.00M derived: sum of 2 quarters · filed 2015-02-13 | $195.00M derived: sum of 3 quarters · filed 2015-02-13 | $140.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | -$36.00M 10-Q · filed 2013-10-23 | -$69.00M derived: sum of 2 quarters · filed 2013-10-23 | -$124.00M 10-Q · filed 2013-10-23 | |
| 2012-06-30 | -$33.00M 10-Q · filed 2013-07-25 | -$88.00M 10-Q · filed 2013-07-25 | ||
| 2012-03-31 | -$55.00M 10-Q · filed 2013-04-25 | |||
| 2011-12-31 | $1.13B 10-K · filed 2014-02-14 | |||
| 2010-12-31 | $27.00M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |